This inventor holds 5 USPTO granted patents. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2001-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2012
Title: Innovations by Rajashehar Betageri: Advancements in Glucocorticoid Mimetics
Introduction
Rajashehar Betageri, an accomplished inventor based in Bethel, CT, has made significant contributions to the field of pharmaceuticals, particularly in the development of glucocorticoid mimetics. With a total of five patents to his name, Betageri's work is instrumental in advancing treatments for various inflammatory and allergic conditions.
Latest Patents
His latest patents focus on glucocorticoid mimetics, which include innovative methods of making these compounds, as well as pharmaceutical compositions derived from them. These patents detail compounds of Formula (IA), which involve specific configurations of compounds relevant to modulating glucocorticoid receptor functions. His inventions provide methods for treating disease states characterized by inflammatory, allergic, or proliferative processes in patients, utilizing these advanced compounds for effective therapeutic interventions.
Career Highlights
Rajashehar Betageri primarily works at Boehringer Ingelheim Pharmaceuticals, Inc., a leading global pharmaceutical company known for its commitment to research and innovation. His role at the company has allowed him to focus on groundbreaking research in pharmacology and therapeutic formulations, significantly contributing to the field.
Collaborations
Throughout his career, Betageri has collaborated with notable colleagues, including Thomas A. Gilmore and David S. Thomson. These professional partnerships have facilitated the exchange of ideas and expertise, leading to advancements in their respective research areas and enhancing the quality of their inventions.
Conclusion
Rajashehar Betageri stands as a prominent figure in pharmaceutical innovation, particularly through his work on glucocorticoid mimetics. His patents not only reflect his expertise and commitment to improving patient outcomes but also highlight the collaborative spirit in the research community. As advancements continue in this field, Betageri's contributions are likely to pave the way for future therapeutic innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile